Showing 1–6 of 6 results
-
Reviews |
Clinical cancer research: the past, present and the future
- David J. Kerr contributes to the University of...
-
News & Views |
Bevacizumab—has it reached its final resting place?
- David J. Kerr is Rhodes Professor of Clinical...
-
Reviews |
Capecitabine: have we got the dose right?
- Professor David J Kerr is a Consultant Medical Oncologist...
-
Comments & Opinion |
The challenge of cancer control in Africa
- David J. Kerr is Rhodes Professor of Clinical...
-
Comments & Opinion |
Open access chemical and clinical probes to support drug discovery
- David J. Kerr is at the Sidra Medical...
-
Reviews |
Genetic prognostic and predictive markers in colorectal cancer
- David J. Kerr is Chief Research Adviser at...